A novel histone deacetylase inhibitor Se-SAHA attenuates isoproterenol-induced heart failure via antioxidative stress and autophagy inhibition

T Cheng, C Liu, Y Wang, G Li, L Feng, S Zhang… - Toxicology and Applied …, 2024 - Elsevier
… Therefore, we hypothesized that Se-SAHA was effective at suppressing autophagy and …
is a novel pan-HDAC inhibitor for the treatment of cardiac hypertrophy and fibrosis during …

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors

Y Han, J Nie, DW Wang, L Ni - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
… –131), decreasing overactive autophagy (132), and upregulating … related signaling pathways
are suppressed, and cardiac … and briefly introduce therapeutic HDAC inhibition (Figure 1). …

Therapeutic effects of histone deacetylase inhibitors on heart disease

P Chun - Archives of Pharmacal Research, 2020 - Springer
… , and regulation of apoptosis, autophagy, and cell cycle arrest. … cardiac hypertrophy,
hypertension, myocardial infarction, … , leading to the suppression of cardiac hypertrophy induced …

… alleviates ventricular remodeling in experimental dilated cardiomyopathy via inhibition of NLRP3 inflammasome activation and promotion of cardiomyocyte autophagy

X Pang, Q Guan, X Lin, N Chang - Cell Biology and Toxicology, 2023 - Springer
… cardiomyocyte autophagy and suppressed NLRP3 … Unlike other HDACs, histone deacetylase
6 (HDAC6) contains … cardiomyocyte autophagy, thereby attenuating ventricular remodeling …

Function of histone methylation and acetylation modifiers in cardiac hypertrophy

J Qin, N Guo, J Tong, Z Wang - Journal of molecular and cellular cardiology, 2021 - Elsevier
Histone acetylation is a reversible modification status … through activation of autophagy,
inhibition of acetylation, suppression of … HDAC inhibitors have been extensively explored for their …

HDAC2 counteracts vascular calcification by activating autophagy in chronic kidney disease

G Zhou, P Liu, C Zhang, Q Huang, Z Zhao… - The FASEB …, 2024 - Wiley Online Library
… induced cardiac hypertrophy by suppressing autophagic activation.… Histone deacetylases 1
and 2 regulate autophagy flux and … Histone deacetylase (HDAC) inhibitors attenuate cardiac

The role of histone deacetylases in cardiac energy metabolism in heart diseases

Q Yu, G Zhao, J Liu, Y Peng, X Xu, F Zhao, Y Shi, C Jin… - Metabolism, 2023 - Elsevier
… Finally, we discuss the application of HDAC inhibitors in heart … Mechanistically, Sirt3 could
reduce cardiac hypertrophy by … PPARα, thereby suppressing FA utilization in the failing heart. (…

CaMKII exacerbates heart failure progression by activating class I HDACs

M Zhang, X Yang, RJ Zimmerman, Q Wang… - … and cellular cardiology, 2020 - Elsevier
… known to inhibit class IIa histone deacetylases (HDACs) [14,15… IIa HDACs prevent cardiac
hypertrophy by the suppression … elicited cardiac hypertrophy [18], or by attenuating autophagy

Histone deacetylase inhibitors for cardiovascular conditions and healthy longevity

JP Ferreira, B Pitt, F Zannad - The Lancet Healthy Longevity, 2021 - thelancet.com
… The use of valproic acid led to attenuated cardiac hypertrophy and fibrosis in these rats. …
-inflammatory and antifibrotic effects is the suppression of profibrotic factors (TGFβ, fibronectin, …

Targeting histone deacetylase in cardiac diseases

J Lu, S Qian, Z Sun - Frontiers in Physiology, 2024 - frontiersin.org
… and are pan-HDAC inhibitors that inhibit all classic HDACs. MS275/… conditions involving
cardiac hypertrophy, myocardial infarction (MI… While miR-21-3p suppressed cardiac hypertrophy, …